Global Alzheimer's Blood Tests Supply, Demand and Key Producers, 2026-2032
The global Alzheimer's Blood Tests market size is expected to reach $ 131 million by 2032, rising at a market growth of 8.4% CAGR during the forecast period (2026-2032).
Alzheimer's blood tests refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Alzheimer's blood tests mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer's disease biomarker research.
The Alzheimer's blood tests market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report studies the global Alzheimer's Blood Tests demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Alzheimer's Blood Tests, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alzheimer's Blood Tests that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Alzheimer's Blood Tests total market, 2021-2032, (USD Million)
Global Alzheimer's Blood Tests total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Alzheimer's Blood Tests total market, key domestic companies, and share, (USD Million)
Global Alzheimer's Blood Tests revenue by player, revenue and market share 2021-2026, (USD Million)
Global Alzheimer's Blood Tests total market by Type, CAGR, 2021-2032, (USD Million)
Global Alzheimer's Blood Tests total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Alzheimer's Blood Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Sysmex, Shimadzu, Diadem, Quanterix, ALZpath, Beckman Coulter Diagnostics, Siemens Healthineers, Vazyme, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Alzheimer's Blood Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Alzheimer's Blood Tests Market, By Region:
1. How big is the global Alzheimer's Blood Tests market?
2. What is the demand of the global Alzheimer's Blood Tests market?
3. What is the year over year growth of the global Alzheimer's Blood Tests market?
4. What is the total value of the global Alzheimer's Blood Tests market?
5. Who are the Major Players in the global Alzheimer's Blood Tests market?
6. What are the growth factors driving the market demand?
Alzheimer's blood tests refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Alzheimer's blood tests mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer's disease biomarker research.
The Alzheimer's blood tests market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report studies the global Alzheimer's Blood Tests demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Alzheimer's Blood Tests, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alzheimer's Blood Tests that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Alzheimer's Blood Tests total market, 2021-2032, (USD Million)
Global Alzheimer's Blood Tests total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Alzheimer's Blood Tests total market, key domestic companies, and share, (USD Million)
Global Alzheimer's Blood Tests revenue by player, revenue and market share 2021-2026, (USD Million)
Global Alzheimer's Blood Tests total market by Type, CAGR, 2021-2032, (USD Million)
Global Alzheimer's Blood Tests total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Alzheimer's Blood Tests market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Sysmex, Shimadzu, Diadem, Quanterix, ALZpath, Beckman Coulter Diagnostics, Siemens Healthineers, Vazyme, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Alzheimer's Blood Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Alzheimer's Blood Tests Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single Biomarker Tests
- Multi-Biomarker Panel Tests
- Others
- Chemiluminescent Immunoassay
- Single-Molecule and Ultra-Sensitive Immunoassay
- Mass Spectrometry-Based Testing
- Others
- Commercialized Products
- Products under Development or Registration
- Research Use Only Products
- Clinical Use
- Non-Clinical Use
- Roche
- Fujirebio
- Sysmex
- Shimadzu
- Diadem
- Quanterix
- ALZpath
- Beckman Coulter Diagnostics
- Siemens Healthineers
- Vazyme
- Hoyotek
- BGI Genomics
- Kemei Diagnostics
- Maya Lightyear
1. How big is the global Alzheimer's Blood Tests market?
2. What is the demand of the global Alzheimer's Blood Tests market?
3. What is the year over year growth of the global Alzheimer's Blood Tests market?
4. What is the total value of the global Alzheimer's Blood Tests market?
5. Who are the Major Players in the global Alzheimer's Blood Tests market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Alzheimer's Blood Tests Introduction
1.2 World Alzheimer's Blood Tests Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Alzheimer's Blood Tests Total Market by Region (by Headquarter Location)
1.3.1 World Alzheimer's Blood Tests Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.3 China Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.4 Europe Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.5 Japan Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.6 South Korea Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.7 ASEAN Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.8 India Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Alzheimer's Blood Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Alzheimer's Blood Tests Consumption Value (2021-2032)
2.2 World Alzheimer's Blood Tests Consumption Value by Region
2.2.1 World Alzheimer's Blood Tests Consumption Value by Region (2021-2026)
2.2.2 World Alzheimer's Blood Tests Consumption Value Forecast by Region (2027-2032)
2.3 United States Alzheimer's Blood Tests Consumption Value (2021-2032)
2.4 China Alzheimer's Blood Tests Consumption Value (2021-2032)
2.5 Europe Alzheimer's Blood Tests Consumption Value (2021-2032)
2.6 Japan Alzheimer's Blood Tests Consumption Value (2021-2032)
2.7 South Korea Alzheimer's Blood Tests Consumption Value (2021-2032)
2.8 ASEAN Alzheimer's Blood Tests Consumption Value (2021-2032)
2.9 India Alzheimer's Blood Tests Consumption Value (2021-2032)
3 WORLD ALZHEIMER'S BLOOD TESTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Alzheimer's Blood Tests Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Alzheimer's Blood Tests Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Alzheimer's Blood Tests in 2025
3.2.3 Global Concentration Ratios (CR8) for Alzheimer's Blood Tests in 2025
3.3 Alzheimer's Blood Tests Company Evaluation Quadrant
3.4 Alzheimer's Blood Tests Market: Overall Company Footprint Analysis
3.4.1 Alzheimer's Blood Tests Market: Region Footprint
3.4.2 Alzheimer's Blood Tests Market: Company Product Type Footprint
3.4.3 Alzheimer's Blood Tests Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Alzheimer's Blood Tests Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Alzheimer's Blood Tests Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Alzheimer's Blood Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Alzheimer's Blood Tests Consumption Value Comparison
4.2.1 United States VS China: Alzheimer's Blood Tests Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Alzheimer's Blood Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Alzheimer's Blood Tests Companies and Market Share, 2021-2026
4.3.1 United States Based Alzheimer's Blood Tests Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Alzheimer's Blood Tests Revenue, (2021-2026)
4.4 China Based Companies Alzheimer's Blood Tests Revenue and Market Share, 2021-2026
4.4.1 China Based Alzheimer's Blood Tests Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Alzheimer's Blood Tests Revenue, (2021-2026)
4.5 Rest of World Based Alzheimer's Blood Tests Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Alzheimer's Blood Tests Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Alzheimer's Blood Tests Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Alzheimer's Blood Tests Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Biomarker Tests
5.2.2 Multi-Biomarker Panel Tests
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Alzheimer's Blood Tests Market Size by Type (2021-2026)
5.3.2 World Alzheimer's Blood Tests Market Size by Type (2027-2032)
5.3.3 World Alzheimer's Blood Tests Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS TESTING TECHNOLOGY
6.1 World Alzheimer's Blood Tests Market Size Overview Testing Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction Testing Technology
6.2.1 Chemiluminescent Immunoassay
6.2.2 Single-Molecule and Ultra-Sensitive Immunoassay
6.2.3 Mass Spectrometry-Based Testing
6.2.4 Others
6.3 Market Segment Testing Technology
6.3.1 World Alzheimer's Blood Tests Market Size Testing Technology (2021-2026)
6.3.2 World Alzheimer's Blood Tests Market Size Testing Technology (2027-2032)
6.3.3 World Alzheimer's Blood Tests Market Size Market Share Testing Technology (2027-2032)
7 MARKET ANALYSIS COMMERCIALIZATION STATUS
7.1 World Alzheimer's Blood Tests Market Size Overview Commercialization Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction Commercialization Status
7.2.1 Commercialized Products
7.2.2 Products under Development or Registration
7.2.3 Research Use Only Products
7.3 Market Segment Commercialization Status
7.3.1 World Alzheimer's Blood Tests Market Size Commercialization Status (2021-2026)
7.3.2 World Alzheimer's Blood Tests Market Size Commercialization Status (2027-2032)
7.3.3 World Alzheimer's Blood Tests Market Size Market Share Commercialization Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Alzheimer's Blood Tests Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Clinical Use
8.2.2 Non-Clinical Use
8.3 Market Segment by Application
8.3.1 World Alzheimer's Blood Tests Market Size by Application (2021-2026)
8.3.2 World Alzheimer's Blood Tests Market Size by Application (2027-2032)
8.3.3 World Alzheimer's Blood Tests Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Alzheimer's Blood Tests Product and Services
9.1.4 Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Fujirebio
9.2.1 Fujirebio Details
9.2.2 Fujirebio Major Business
9.2.3 Fujirebio Alzheimer's Blood Tests Product and Services
9.2.4 Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Fujirebio Recent Developments/Updates
9.2.6 Fujirebio Competitive Strengths & Weaknesses
9.3 Sysmex
9.3.1 Sysmex Details
9.3.2 Sysmex Major Business
9.3.3 Sysmex Alzheimer's Blood Tests Product and Services
9.3.4 Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sysmex Recent Developments/Updates
9.3.6 Sysmex Competitive Strengths & Weaknesses
9.4 Shimadzu
9.4.1 Shimadzu Details
9.4.2 Shimadzu Major Business
9.4.3 Shimadzu Alzheimer's Blood Tests Product and Services
9.4.4 Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Shimadzu Recent Developments/Updates
9.4.6 Shimadzu Competitive Strengths & Weaknesses
9.5 Diadem
9.5.1 Diadem Details
9.5.2 Diadem Major Business
9.5.3 Diadem Alzheimer's Blood Tests Product and Services
9.5.4 Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Diadem Recent Developments/Updates
9.5.6 Diadem Competitive Strengths & Weaknesses
9.6 Quanterix
9.6.1 Quanterix Details
9.6.2 Quanterix Major Business
9.6.3 Quanterix Alzheimer's Blood Tests Product and Services
9.6.4 Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Quanterix Recent Developments/Updates
9.6.6 Quanterix Competitive Strengths & Weaknesses
9.7 ALZpath
9.7.1 ALZpath Details
9.7.2 ALZpath Major Business
9.7.3 ALZpath Alzheimer's Blood Tests Product and Services
9.7.4 ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ALZpath Recent Developments/Updates
9.7.6 ALZpath Competitive Strengths & Weaknesses
9.8 Beckman Coulter Diagnostics
9.8.1 Beckman Coulter Diagnostics Details
9.8.2 Beckman Coulter Diagnostics Major Business
9.8.3 Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Services
9.8.4 Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Beckman Coulter Diagnostics Recent Developments/Updates
9.8.6 Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
9.9 Siemens Healthineers
9.9.1 Siemens Healthineers Details
9.9.2 Siemens Healthineers Major Business
9.9.3 Siemens Healthineers Alzheimer's Blood Tests Product and Services
9.9.4 Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Siemens Healthineers Recent Developments/Updates
9.9.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.10 Vazyme
9.10.1 Vazyme Details
9.10.2 Vazyme Major Business
9.10.3 Vazyme Alzheimer's Blood Tests Product and Services
9.10.4 Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vazyme Recent Developments/Updates
9.10.6 Vazyme Competitive Strengths & Weaknesses
9.11 Hoyotek
9.11.1 Hoyotek Details
9.11.2 Hoyotek Major Business
9.11.3 Hoyotek Alzheimer's Blood Tests Product and Services
9.11.4 Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Hoyotek Recent Developments/Updates
9.11.6 Hoyotek Competitive Strengths & Weaknesses
9.12 BGI Genomics
9.12.1 BGI Genomics Details
9.12.2 BGI Genomics Major Business
9.12.3 BGI Genomics Alzheimer's Blood Tests Product and Services
9.12.4 BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BGI Genomics Recent Developments/Updates
9.12.6 BGI Genomics Competitive Strengths & Weaknesses
9.13 Kemei Diagnostics
9.13.1 Kemei Diagnostics Details
9.13.2 Kemei Diagnostics Major Business
9.13.3 Kemei Diagnostics Alzheimer's Blood Tests Product and Services
9.13.4 Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Kemei Diagnostics Recent Developments/Updates
9.13.6 Kemei Diagnostics Competitive Strengths & Weaknesses
9.14 Maya Lightyear
9.14.1 Maya Lightyear Details
9.14.2 Maya Lightyear Major Business
9.14.3 Maya Lightyear Alzheimer's Blood Tests Product and Services
9.14.4 Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Maya Lightyear Recent Developments/Updates
9.14.6 Maya Lightyear Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Alzheimer's Blood Tests Industry Chain
10.2 Alzheimer's Blood Tests Upstream Analysis
10.3 Alzheimer's Blood Tests Midstream Analysis
10.4 Alzheimer's Blood Tests Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Alzheimer's Blood Tests Introduction
1.2 World Alzheimer's Blood Tests Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Alzheimer's Blood Tests Total Market by Region (by Headquarter Location)
1.3.1 World Alzheimer's Blood Tests Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.3 China Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.4 Europe Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.5 Japan Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.6 South Korea Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.7 ASEAN Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.3.8 India Based Company Alzheimer's Blood Tests Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Alzheimer's Blood Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Alzheimer's Blood Tests Consumption Value (2021-2032)
2.2 World Alzheimer's Blood Tests Consumption Value by Region
2.2.1 World Alzheimer's Blood Tests Consumption Value by Region (2021-2026)
2.2.2 World Alzheimer's Blood Tests Consumption Value Forecast by Region (2027-2032)
2.3 United States Alzheimer's Blood Tests Consumption Value (2021-2032)
2.4 China Alzheimer's Blood Tests Consumption Value (2021-2032)
2.5 Europe Alzheimer's Blood Tests Consumption Value (2021-2032)
2.6 Japan Alzheimer's Blood Tests Consumption Value (2021-2032)
2.7 South Korea Alzheimer's Blood Tests Consumption Value (2021-2032)
2.8 ASEAN Alzheimer's Blood Tests Consumption Value (2021-2032)
2.9 India Alzheimer's Blood Tests Consumption Value (2021-2032)
3 WORLD ALZHEIMER'S BLOOD TESTS COMPANIES COMPETITIVE ANALYSIS
3.1 World Alzheimer's Blood Tests Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Alzheimer's Blood Tests Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Alzheimer's Blood Tests in 2025
3.2.3 Global Concentration Ratios (CR8) for Alzheimer's Blood Tests in 2025
3.3 Alzheimer's Blood Tests Company Evaluation Quadrant
3.4 Alzheimer's Blood Tests Market: Overall Company Footprint Analysis
3.4.1 Alzheimer's Blood Tests Market: Region Footprint
3.4.2 Alzheimer's Blood Tests Market: Company Product Type Footprint
3.4.3 Alzheimer's Blood Tests Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Alzheimer's Blood Tests Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Alzheimer's Blood Tests Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Alzheimer's Blood Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Alzheimer's Blood Tests Consumption Value Comparison
4.2.1 United States VS China: Alzheimer's Blood Tests Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Alzheimer's Blood Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Alzheimer's Blood Tests Companies and Market Share, 2021-2026
4.3.1 United States Based Alzheimer's Blood Tests Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Alzheimer's Blood Tests Revenue, (2021-2026)
4.4 China Based Companies Alzheimer's Blood Tests Revenue and Market Share, 2021-2026
4.4.1 China Based Alzheimer's Blood Tests Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Alzheimer's Blood Tests Revenue, (2021-2026)
4.5 Rest of World Based Alzheimer's Blood Tests Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Alzheimer's Blood Tests Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Alzheimer's Blood Tests Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Alzheimer's Blood Tests Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Biomarker Tests
5.2.2 Multi-Biomarker Panel Tests
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Alzheimer's Blood Tests Market Size by Type (2021-2026)
5.3.2 World Alzheimer's Blood Tests Market Size by Type (2027-2032)
5.3.3 World Alzheimer's Blood Tests Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS TESTING TECHNOLOGY
6.1 World Alzheimer's Blood Tests Market Size Overview Testing Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction Testing Technology
6.2.1 Chemiluminescent Immunoassay
6.2.2 Single-Molecule and Ultra-Sensitive Immunoassay
6.2.3 Mass Spectrometry-Based Testing
6.2.4 Others
6.3 Market Segment Testing Technology
6.3.1 World Alzheimer's Blood Tests Market Size Testing Technology (2021-2026)
6.3.2 World Alzheimer's Blood Tests Market Size Testing Technology (2027-2032)
6.3.3 World Alzheimer's Blood Tests Market Size Market Share Testing Technology (2027-2032)
7 MARKET ANALYSIS COMMERCIALIZATION STATUS
7.1 World Alzheimer's Blood Tests Market Size Overview Commercialization Status: 2021 VS 2025 VS 2032
7.2 Segment Introduction Commercialization Status
7.2.1 Commercialized Products
7.2.2 Products under Development or Registration
7.2.3 Research Use Only Products
7.3 Market Segment Commercialization Status
7.3.1 World Alzheimer's Blood Tests Market Size Commercialization Status (2021-2026)
7.3.2 World Alzheimer's Blood Tests Market Size Commercialization Status (2027-2032)
7.3.3 World Alzheimer's Blood Tests Market Size Market Share Commercialization Status (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Alzheimer's Blood Tests Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Clinical Use
8.2.2 Non-Clinical Use
8.3 Market Segment by Application
8.3.1 World Alzheimer's Blood Tests Market Size by Application (2021-2026)
8.3.2 World Alzheimer's Blood Tests Market Size by Application (2027-2032)
8.3.3 World Alzheimer's Blood Tests Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Alzheimer's Blood Tests Product and Services
9.1.4 Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Fujirebio
9.2.1 Fujirebio Details
9.2.2 Fujirebio Major Business
9.2.3 Fujirebio Alzheimer's Blood Tests Product and Services
9.2.4 Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Fujirebio Recent Developments/Updates
9.2.6 Fujirebio Competitive Strengths & Weaknesses
9.3 Sysmex
9.3.1 Sysmex Details
9.3.2 Sysmex Major Business
9.3.3 Sysmex Alzheimer's Blood Tests Product and Services
9.3.4 Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Sysmex Recent Developments/Updates
9.3.6 Sysmex Competitive Strengths & Weaknesses
9.4 Shimadzu
9.4.1 Shimadzu Details
9.4.2 Shimadzu Major Business
9.4.3 Shimadzu Alzheimer's Blood Tests Product and Services
9.4.4 Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Shimadzu Recent Developments/Updates
9.4.6 Shimadzu Competitive Strengths & Weaknesses
9.5 Diadem
9.5.1 Diadem Details
9.5.2 Diadem Major Business
9.5.3 Diadem Alzheimer's Blood Tests Product and Services
9.5.4 Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Diadem Recent Developments/Updates
9.5.6 Diadem Competitive Strengths & Weaknesses
9.6 Quanterix
9.6.1 Quanterix Details
9.6.2 Quanterix Major Business
9.6.3 Quanterix Alzheimer's Blood Tests Product and Services
9.6.4 Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Quanterix Recent Developments/Updates
9.6.6 Quanterix Competitive Strengths & Weaknesses
9.7 ALZpath
9.7.1 ALZpath Details
9.7.2 ALZpath Major Business
9.7.3 ALZpath Alzheimer's Blood Tests Product and Services
9.7.4 ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ALZpath Recent Developments/Updates
9.7.6 ALZpath Competitive Strengths & Weaknesses
9.8 Beckman Coulter Diagnostics
9.8.1 Beckman Coulter Diagnostics Details
9.8.2 Beckman Coulter Diagnostics Major Business
9.8.3 Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Services
9.8.4 Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Beckman Coulter Diagnostics Recent Developments/Updates
9.8.6 Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
9.9 Siemens Healthineers
9.9.1 Siemens Healthineers Details
9.9.2 Siemens Healthineers Major Business
9.9.3 Siemens Healthineers Alzheimer's Blood Tests Product and Services
9.9.4 Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Siemens Healthineers Recent Developments/Updates
9.9.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.10 Vazyme
9.10.1 Vazyme Details
9.10.2 Vazyme Major Business
9.10.3 Vazyme Alzheimer's Blood Tests Product and Services
9.10.4 Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Vazyme Recent Developments/Updates
9.10.6 Vazyme Competitive Strengths & Weaknesses
9.11 Hoyotek
9.11.1 Hoyotek Details
9.11.2 Hoyotek Major Business
9.11.3 Hoyotek Alzheimer's Blood Tests Product and Services
9.11.4 Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Hoyotek Recent Developments/Updates
9.11.6 Hoyotek Competitive Strengths & Weaknesses
9.12 BGI Genomics
9.12.1 BGI Genomics Details
9.12.2 BGI Genomics Major Business
9.12.3 BGI Genomics Alzheimer's Blood Tests Product and Services
9.12.4 BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BGI Genomics Recent Developments/Updates
9.12.6 BGI Genomics Competitive Strengths & Weaknesses
9.13 Kemei Diagnostics
9.13.1 Kemei Diagnostics Details
9.13.2 Kemei Diagnostics Major Business
9.13.3 Kemei Diagnostics Alzheimer's Blood Tests Product and Services
9.13.4 Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Kemei Diagnostics Recent Developments/Updates
9.13.6 Kemei Diagnostics Competitive Strengths & Weaknesses
9.14 Maya Lightyear
9.14.1 Maya Lightyear Details
9.14.2 Maya Lightyear Major Business
9.14.3 Maya Lightyear Alzheimer's Blood Tests Product and Services
9.14.4 Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Maya Lightyear Recent Developments/Updates
9.14.6 Maya Lightyear Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Alzheimer's Blood Tests Industry Chain
10.2 Alzheimer's Blood Tests Upstream Analysis
10.3 Alzheimer's Blood Tests Midstream Analysis
10.4 Alzheimer's Blood Tests Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Alzheimer's Blood Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Alzheimer's Blood Tests Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Alzheimer's Blood Tests Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Alzheimer's Blood Tests Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Alzheimer's Blood Tests Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Alzheimer's Blood Tests Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Alzheimer's Blood Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Alzheimer's Blood Tests Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Alzheimer's Blood Tests Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Alzheimer's Blood Tests Players in 2025
Table 12. World Alzheimer's Blood Tests Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Alzheimer's Blood Tests Company Evaluation Quadrant
Table 14. Head Office of Key Alzheimer's Blood Tests Players
Table 15. Alzheimer's Blood Tests Market: Company Product Type Footprint
Table 16. Alzheimer's Blood Tests Market: Company Product Application Footprint
Table 17. Alzheimer's Blood Tests Mergers & Acquisitions Activity
Table 18. United States VS China Alzheimer's Blood Tests Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Alzheimer's Blood Tests Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Alzheimer's Blood Tests Companies, Headquarters (States, Country)
Table 21. United States Based Companies Alzheimer's Blood Tests Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Alzheimer's Blood Tests Revenue Market Share (2021-2026)
Table 23. China Based Alzheimer's Blood Tests Companies, Headquarters (Province, Country)
Table 24. China Based Companies Alzheimer's Blood Tests Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Alzheimer's Blood Tests Revenue Market Share (2021-2026)
Table 26. Rest of World Based Alzheimer's Blood Tests Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Alzheimer's Blood Tests Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Alzheimer's Blood Tests Revenue Market Share (2021-2026)
Table 29. World Alzheimer's Blood Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Alzheimer's Blood Tests Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Alzheimer's Blood Tests Market Size by Type (2027-2032) & (USD Million)
Table 32. World Alzheimer's Blood Tests Market Size Testing Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Alzheimer's Blood Tests Market Size Value Testing Technology (2021-2026) & (USD Million)
Table 34. World Alzheimer's Blood Tests Market Size Testing Technology (2027-2032) & (USD Million)
Table 35. World Alzheimer's Blood Tests Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 36. World Alzheimer's Blood Tests Market Size Value Commercialization Status (2021-2026) & (USD Million)
Table 37. World Alzheimer's Blood Tests Market Size Commercialization Status (2027-2032) & (USD Million)
Table 38. World Alzheimer's Blood Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Alzheimer's Blood Tests Market Size by Application (2021-2026) & (USD Million)
Table 40. World Alzheimer's Blood Tests Market Size by Application (2027-2032) & (USD Million)
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Alzheimer's Blood Tests Product and Services
Table 44. Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 48. Fujirebio Major Business
Table 49. Fujirebio Alzheimer's Blood Tests Product and Services
Table 50. Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Fujirebio Recent Developments/Updates
Table 52. Fujirebio Competitive Strengths & Weaknesses
Table 53. Sysmex Basic Information, Manufacturing Base and Competitors
Table 54. Sysmex Major Business
Table 55. Sysmex Alzheimer's Blood Tests Product and Services
Table 56. Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sysmex Recent Developments/Updates
Table 58. Sysmex Competitive Strengths & Weaknesses
Table 59. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 60. Shimadzu Major Business
Table 61. Shimadzu Alzheimer's Blood Tests Product and Services
Table 62. Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Shimadzu Recent Developments/Updates
Table 64. Shimadzu Competitive Strengths & Weaknesses
Table 65. Diadem Basic Information, Manufacturing Base and Competitors
Table 66. Diadem Major Business
Table 67. Diadem Alzheimer's Blood Tests Product and Services
Table 68. Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Diadem Recent Developments/Updates
Table 70. Diadem Competitive Strengths & Weaknesses
Table 71. Quanterix Basic Information, Manufacturing Base and Competitors
Table 72. Quanterix Major Business
Table 73. Quanterix Alzheimer's Blood Tests Product and Services
Table 74. Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Quanterix Recent Developments/Updates
Table 76. Quanterix Competitive Strengths & Weaknesses
Table 77. ALZpath Basic Information, Manufacturing Base and Competitors
Table 78. ALZpath Major Business
Table 79. ALZpath Alzheimer's Blood Tests Product and Services
Table 80. ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ALZpath Recent Developments/Updates
Table 82. ALZpath Competitive Strengths & Weaknesses
Table 83. Beckman Coulter Diagnostics Basic Information, Manufacturing Base and Competitors
Table 84. Beckman Coulter Diagnostics Major Business
Table 85. Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Services
Table 86. Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Beckman Coulter Diagnostics Recent Developments/Updates
Table 88. Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
Table 89. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 90. Siemens Healthineers Major Business
Table 91. Siemens Healthineers Alzheimer's Blood Tests Product and Services
Table 92. Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Siemens Healthineers Recent Developments/Updates
Table 94. Siemens Healthineers Competitive Strengths & Weaknesses
Table 95. Vazyme Basic Information, Manufacturing Base and Competitors
Table 96. Vazyme Major Business
Table 97. Vazyme Alzheimer's Blood Tests Product and Services
Table 98. Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vazyme Recent Developments/Updates
Table 100. Vazyme Competitive Strengths & Weaknesses
Table 101. Hoyotek Basic Information, Manufacturing Base and Competitors
Table 102. Hoyotek Major Business
Table 103. Hoyotek Alzheimer's Blood Tests Product and Services
Table 104. Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hoyotek Recent Developments/Updates
Table 106. Hoyotek Competitive Strengths & Weaknesses
Table 107. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 108. BGI Genomics Major Business
Table 109. BGI Genomics Alzheimer's Blood Tests Product and Services
Table 110. BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BGI Genomics Recent Developments/Updates
Table 112. BGI Genomics Competitive Strengths & Weaknesses
Table 113. Kemei Diagnostics Basic Information, Manufacturing Base and Competitors
Table 114. Kemei Diagnostics Major Business
Table 115. Kemei Diagnostics Alzheimer's Blood Tests Product and Services
Table 116. Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Kemei Diagnostics Recent Developments/Updates
Table 118. Kemei Diagnostics Competitive Strengths & Weaknesses
Table 119. Maya Lightyear Basic Information, Manufacturing Base and Competitors
Table 120. Maya Lightyear Major Business
Table 121. Maya Lightyear Alzheimer's Blood Tests Product and Services
Table 122. Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Maya Lightyear Recent Developments/Updates
Table 124. Maya Lightyear Competitive Strengths & Weaknesses
Table 125. Global Key Players of Alzheimer's Blood Tests Upstream (Raw Materials)
Table 126. Global Alzheimer's Blood Tests Typical Customers
Table 1. World Alzheimer's Blood Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Alzheimer's Blood Tests Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Alzheimer's Blood Tests Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Alzheimer's Blood Tests Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Alzheimer's Blood Tests Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Alzheimer's Blood Tests Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Alzheimer's Blood Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Alzheimer's Blood Tests Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Alzheimer's Blood Tests Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Alzheimer's Blood Tests Players in 2025
Table 12. World Alzheimer's Blood Tests Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Alzheimer's Blood Tests Company Evaluation Quadrant
Table 14. Head Office of Key Alzheimer's Blood Tests Players
Table 15. Alzheimer's Blood Tests Market: Company Product Type Footprint
Table 16. Alzheimer's Blood Tests Market: Company Product Application Footprint
Table 17. Alzheimer's Blood Tests Mergers & Acquisitions Activity
Table 18. United States VS China Alzheimer's Blood Tests Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Alzheimer's Blood Tests Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Alzheimer's Blood Tests Companies, Headquarters (States, Country)
Table 21. United States Based Companies Alzheimer's Blood Tests Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Alzheimer's Blood Tests Revenue Market Share (2021-2026)
Table 23. China Based Alzheimer's Blood Tests Companies, Headquarters (Province, Country)
Table 24. China Based Companies Alzheimer's Blood Tests Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Alzheimer's Blood Tests Revenue Market Share (2021-2026)
Table 26. Rest of World Based Alzheimer's Blood Tests Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Alzheimer's Blood Tests Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Alzheimer's Blood Tests Revenue Market Share (2021-2026)
Table 29. World Alzheimer's Blood Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Alzheimer's Blood Tests Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Alzheimer's Blood Tests Market Size by Type (2027-2032) & (USD Million)
Table 32. World Alzheimer's Blood Tests Market Size Testing Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Alzheimer's Blood Tests Market Size Value Testing Technology (2021-2026) & (USD Million)
Table 34. World Alzheimer's Blood Tests Market Size Testing Technology (2027-2032) & (USD Million)
Table 35. World Alzheimer's Blood Tests Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 36. World Alzheimer's Blood Tests Market Size Value Commercialization Status (2021-2026) & (USD Million)
Table 37. World Alzheimer's Blood Tests Market Size Commercialization Status (2027-2032) & (USD Million)
Table 38. World Alzheimer's Blood Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Alzheimer's Blood Tests Market Size by Application (2021-2026) & (USD Million)
Table 40. World Alzheimer's Blood Tests Market Size by Application (2027-2032) & (USD Million)
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Alzheimer's Blood Tests Product and Services
Table 44. Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Fujirebio Basic Information, Manufacturing Base and Competitors
Table 48. Fujirebio Major Business
Table 49. Fujirebio Alzheimer's Blood Tests Product and Services
Table 50. Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Fujirebio Recent Developments/Updates
Table 52. Fujirebio Competitive Strengths & Weaknesses
Table 53. Sysmex Basic Information, Manufacturing Base and Competitors
Table 54. Sysmex Major Business
Table 55. Sysmex Alzheimer's Blood Tests Product and Services
Table 56. Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Sysmex Recent Developments/Updates
Table 58. Sysmex Competitive Strengths & Weaknesses
Table 59. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 60. Shimadzu Major Business
Table 61. Shimadzu Alzheimer's Blood Tests Product and Services
Table 62. Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Shimadzu Recent Developments/Updates
Table 64. Shimadzu Competitive Strengths & Weaknesses
Table 65. Diadem Basic Information, Manufacturing Base and Competitors
Table 66. Diadem Major Business
Table 67. Diadem Alzheimer's Blood Tests Product and Services
Table 68. Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Diadem Recent Developments/Updates
Table 70. Diadem Competitive Strengths & Weaknesses
Table 71. Quanterix Basic Information, Manufacturing Base and Competitors
Table 72. Quanterix Major Business
Table 73. Quanterix Alzheimer's Blood Tests Product and Services
Table 74. Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Quanterix Recent Developments/Updates
Table 76. Quanterix Competitive Strengths & Weaknesses
Table 77. ALZpath Basic Information, Manufacturing Base and Competitors
Table 78. ALZpath Major Business
Table 79. ALZpath Alzheimer's Blood Tests Product and Services
Table 80. ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ALZpath Recent Developments/Updates
Table 82. ALZpath Competitive Strengths & Weaknesses
Table 83. Beckman Coulter Diagnostics Basic Information, Manufacturing Base and Competitors
Table 84. Beckman Coulter Diagnostics Major Business
Table 85. Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Services
Table 86. Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Beckman Coulter Diagnostics Recent Developments/Updates
Table 88. Beckman Coulter Diagnostics Competitive Strengths & Weaknesses
Table 89. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 90. Siemens Healthineers Major Business
Table 91. Siemens Healthineers Alzheimer's Blood Tests Product and Services
Table 92. Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Siemens Healthineers Recent Developments/Updates
Table 94. Siemens Healthineers Competitive Strengths & Weaknesses
Table 95. Vazyme Basic Information, Manufacturing Base and Competitors
Table 96. Vazyme Major Business
Table 97. Vazyme Alzheimer's Blood Tests Product and Services
Table 98. Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Vazyme Recent Developments/Updates
Table 100. Vazyme Competitive Strengths & Weaknesses
Table 101. Hoyotek Basic Information, Manufacturing Base and Competitors
Table 102. Hoyotek Major Business
Table 103. Hoyotek Alzheimer's Blood Tests Product and Services
Table 104. Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hoyotek Recent Developments/Updates
Table 106. Hoyotek Competitive Strengths & Weaknesses
Table 107. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 108. BGI Genomics Major Business
Table 109. BGI Genomics Alzheimer's Blood Tests Product and Services
Table 110. BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BGI Genomics Recent Developments/Updates
Table 112. BGI Genomics Competitive Strengths & Weaknesses
Table 113. Kemei Diagnostics Basic Information, Manufacturing Base and Competitors
Table 114. Kemei Diagnostics Major Business
Table 115. Kemei Diagnostics Alzheimer's Blood Tests Product and Services
Table 116. Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Kemei Diagnostics Recent Developments/Updates
Table 118. Kemei Diagnostics Competitive Strengths & Weaknesses
Table 119. Maya Lightyear Basic Information, Manufacturing Base and Competitors
Table 120. Maya Lightyear Major Business
Table 121. Maya Lightyear Alzheimer's Blood Tests Product and Services
Table 122. Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Maya Lightyear Recent Developments/Updates
Table 124. Maya Lightyear Competitive Strengths & Weaknesses
Table 125. Global Key Players of Alzheimer's Blood Tests Upstream (Raw Materials)
Table 126. Global Alzheimer's Blood Tests Typical Customers
LIST OF FIGURES
Figure 1. Alzheimer's Blood Tests Picture
Figure 2. World Alzheimer's Blood Tests Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Alzheimer's Blood Tests Total Revenue (2021-2032) & (USD Million)
Figure 4. World Alzheimer's Blood Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Alzheimer's Blood Tests Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 13. Alzheimer's Blood Tests Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 16. World Alzheimer's Blood Tests Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 18. China Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 23. India Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Alzheimer's Blood Tests by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Alzheimer's Blood Tests Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Alzheimer's Blood Tests Markets in 2025
Figure 27. United States VS China: Alzheimer's Blood Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Alzheimer's Blood Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Alzheimer's Blood Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Alzheimer's Blood Tests Market Size Market Share by Type in 2025
Figure 31. Single Biomarker Tests
Figure 32. Multi-Biomarker Panel Tests
Figure 33. Others
Figure 34. World Alzheimer's Blood Tests Market Size Market Share by Type (2021-2032)
Figure 35. World Alzheimer's Blood Tests Market Size Testing Technology, (USD Million), 2021 & 2025 & 2032
Figure 36. World Alzheimer's Blood Tests Market Size Market Share Testing Technology in 2025
Figure 37. Chemiluminescent Immunoassay
Figure 38. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 39. Mass Spectrometry-Based Testing
Figure 40. Others
Figure 41. World Alzheimer's Blood Tests Market Size Market Share Testing Technology (2021-2032)
Figure 42. World Alzheimer's Blood Tests Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World Alzheimer's Blood Tests Market Size Market Share Commercialization Status in 2025
Figure 44. Commercialized Products
Figure 45. Products under Development or Registration
Figure 46. Research Use Only Products
Figure 47. World Alzheimer's Blood Tests Market Size Market Share Commercialization Status (2021-2032)
Figure 48. World Alzheimer's Blood Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Alzheimer's Blood Tests Market Size Market Share by Application in 2025
Figure 50. Clinical Use
Figure 51. Non-Clinical Use
Figure 52. World Alzheimer's Blood Tests Market Size Market Share by Application (2021-2032)
Figure 53. Alzheimer's Blood Tests Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Alzheimer's Blood Tests Picture
Figure 2. World Alzheimer's Blood Tests Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Alzheimer's Blood Tests Total Revenue (2021-2032) & (USD Million)
Figure 4. World Alzheimer's Blood Tests Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Alzheimer's Blood Tests Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Alzheimer's Blood Tests Revenue (2021-2032) & (USD Million)
Figure 13. Alzheimer's Blood Tests Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 16. World Alzheimer's Blood Tests Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 18. China Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 23. India Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Alzheimer's Blood Tests by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Alzheimer's Blood Tests Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Alzheimer's Blood Tests Markets in 2025
Figure 27. United States VS China: Alzheimer's Blood Tests Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Alzheimer's Blood Tests Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Alzheimer's Blood Tests Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Alzheimer's Blood Tests Market Size Market Share by Type in 2025
Figure 31. Single Biomarker Tests
Figure 32. Multi-Biomarker Panel Tests
Figure 33. Others
Figure 34. World Alzheimer's Blood Tests Market Size Market Share by Type (2021-2032)
Figure 35. World Alzheimer's Blood Tests Market Size Testing Technology, (USD Million), 2021 & 2025 & 2032
Figure 36. World Alzheimer's Blood Tests Market Size Market Share Testing Technology in 2025
Figure 37. Chemiluminescent Immunoassay
Figure 38. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 39. Mass Spectrometry-Based Testing
Figure 40. Others
Figure 41. World Alzheimer's Blood Tests Market Size Market Share Testing Technology (2021-2032)
Figure 42. World Alzheimer's Blood Tests Market Size Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 43. World Alzheimer's Blood Tests Market Size Market Share Commercialization Status in 2025
Figure 44. Commercialized Products
Figure 45. Products under Development or Registration
Figure 46. Research Use Only Products
Figure 47. World Alzheimer's Blood Tests Market Size Market Share Commercialization Status (2021-2032)
Figure 48. World Alzheimer's Blood Tests Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Alzheimer's Blood Tests Market Size Market Share by Application in 2025
Figure 50. Clinical Use
Figure 51. Non-Clinical Use
Figure 52. World Alzheimer's Blood Tests Market Size Market Share by Application (2021-2032)
Figure 53. Alzheimer's Blood Tests Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
